Patrizio Lancellotti is an expert in Cardiology at Centre Hospitalier Universitaire de Liège (Belgium). As of October 2026, ScienceLeadR ranks Patrizio Lancellotti in the top 1% of experts worldwide for Mitral Valve Insufficiency, Ventricular Outflow Obstruction and Endocarditis. Patrizio Lancellotti has authored 1,272 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 2 of them ongoing. SLR score: 4,835 (community average: 125). How the SLR is computed.

LeadR Profile

4 835 ScienceLeadR Reputation 4835
Network Map

Cardiology

Subspecialties: Medical Imaging - Internal Medicine - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Patrizio Lancellotti, MD, PhD, FESC, FACC

Born on October 27, 1970, in Charleroi, Belgium

Specialties: Cardiology – Structural Interventions – Cardiovascular Imaging – Intensive Care

Primary Affiliation: University of Liège

Tenured Professor since January 25, 2025

Academic Position: Full Professor of Medicine

Hospital Appointment: Head of the Department of Cardiology, University Hospital of Liège (CHU)

Biographical Sketch

Professor Patrizio Lancellotti has followed an atypical academic path. He completed his secondary studies in applied chemistry at the “Université du Travail Paul Pastur” before pursuing medical studies. He earned his MD degree in 1995 from the University of Liège, followed by a specialization in cardiology and additional training in intensive care medicine, granting him the title of intensive care cardiologist in 2001. He defended a PhD thesis in 2002 and later completed his habilitation (aggregation) on dynamic mitral regurgitation in 2005.

In 2002, he was appointed Director of the Echocardiography Laboratory, and in 2010, he co-founded one of the first dedicated heart valve clinics in Europe. Since 2017, he has led the Department of Cardiology at the University Hospital of Liège, where he teaches cardiovascular medicine and rehabilitation to medical and physical therapy students.

Professor Lancellotti is a member of multiple editorial boards and currently serves as Associate Editor of European Heart Journal - Open, European Heart Journal – Cardiovascular Imaging, EuroIntervention, and Revue Médicale de Liège. He is Editor-in-Chief of Acta Cardiologica. As a highly prolific clinician-scientist, he has authored over 900 peer-reviewed articles and presented more than 250 scientific communications at national and international meetings. He has obtained major research grants, including ERC (Starting and PoC), FEDER, and Interreg funding, while maintaining an active clinical and academic career.

He has supervised more than 10 PhD candidates in both clinical and basic cardiovascular research and served as jury member for numerous dissertations in Belgium and abroad. He has also co-edited several reference books in cardio-oncology, echocardiography, multimodal imaging, and valvular heart disease. He was ranked among the world’s top 1% most cited researchers in 2018, 2019, and 2023 (Clarivate, Web of Science).

Professor Lancellotti is Past-President of the European Association of Cardiovascular Imaging (EACVI), the European Council on Valvular Heart Disease, and the Belgian Society of Cardiology.

Selected Awards and Distinctions

  1. 1994: Grant from the Association of Medical Delegates of Liège and Luxembourg
  2. 2001: Pfizer Educational Grant for DES in Cardiology
  3. 2001: Young Investigator Award – Belgian Society of Cardiology
  4. 2004: Jacqueline Bernheim Award – Foundation for Cardiac Surgery
  5. 2005: Best Poster – French Society of Cardiology: Cardiac resynchronization and dynamic mitral regurgitation
  6. 2005: Best Poster – ESC Congress, Stockholm: Long-term outcome in heart failure with dynamic MR
  7. 2006: Award from Fondation Jaumain
  8. 2007: Seed Grant, Faculty of Medicine – Animal model of ischemic mitral regurgitation
  9. 2008: InBev-Baillet Latour Clinical Research Award (Cardiovascular Diseases)
  10. 2008: Lambertine Lacroix Prize (Cardiovascular Medicine)
  11. 2010 →: Fellow of the European Society of Cardiology (FESC)
  12. 2012 →: Fellow of the American College of Cardiology (FACC)
  13. 2013: Invited Professor – 8th Annual Tajik/Seward Lectureship, Mayo Clinic
  14. 2014: Honorary Member – British Society of Echocardiography
  15. 2014: Honorary Citizen of Liège, Belgium
  16. 2014: Honorary Member – Hungarian Society of Cardiology
  17. 2015: Edler Prize – Universidad Complutense, Madrid
  18. 2016: Grant – Cancer Center, University of Liège
  19. 2016: Silver Medal – European Society of Cardiology (ESC Congress, Rome)
  20. 2019: Best Moderated Poster – ESC Congress, Paris: Radiotherapy impact on TAVI outcomes
  21. 2019: Best Poster – ISTH Congress, Melbourne: Soluble GPVI and LV remodeling in AS
  22. 2020: FNRS Joseph Maisin Quinquennial Prize – Clinical Biomedical Sciences
  23. 2020: Grant from the Province of Liège – Therapeutic Education & New Technologies in Heart Failure


Organizations

Career arc: 1995 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Liège

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Liver Extracellular Volume in Patients With Tricuspid Regurgitation: A Novel Prognostic Marker.
PMID 42944652 — heart failure, liver, tricuspid valve insufficiency
JACC Cardiovasc Imaging20260
[Sudden cardiac death and hypertrophic cardiomyopathy : risk assessment and indications for implantable cardioverter-defibrillator].
PMID 42861536 — risk assessment, cardiomyopathy, hypertrophic, death, sudden, cardiac, defibrillators, implantable, cardiomyopathies, defibrillators
Rev Med Liege20260
[Integration of clinical, biological and imaging data in medical decision-making].
PMID 42861530 — clinical decision-making, decision making
Rev Med Liege20260
[Leadless pacemakers : current evidence and future perspectives].
PMID 42861534
Rev Med Liege20260
[Pulmonary hypertension associated with interstitial lung diseases: current state of the art].
PMID 42861537 — hypertension, lung, hypertension, pulmonary, therapeutics, lung diseases, lung diseases, interstitial
Rev Med Liege20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 8
Phase 3 6

By status:

Completed 9
Unknown 2
Active not recruiting 1
Recruiting 1
Terminated 1

By type:

Interventional 9
Observational 5

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 1
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The TRICURE EU Pivotal Study
NCT06581471 — heart valve diseases, heart, cardiovascular diseases, tricuspid valve, tricuspid valve insufficiency, heart valves
N/ARecruiting2024
The TRICURE First in Human Trial
NCT05126030 — heart, tricuspid valve, tricuspid valve insufficiency, heart valves
N/AActive not recruiting2022

LeadR Networks

Main global connection map